Subconjunctival 0.1% epinephrine versus placebo in maintenance of mydriasis during vitrectomy: a randomized controlled trial
Open Access
- 17 October 2018
- journal article
- research article
- Published by Springer Nature in International Journal of Retina and Vitreous
- Vol. 4 (1) , 38
Abstract
Background: Pupil dilation and mydriasis maintenance throughout vitreoretinal surgeries are important to allow satisfactory fundus visualization and reduce risk of complications. The purpose of this study is to evaluate the role of subconjunctival epinephrine 0.1% injection in mydriasis maintenance during vitrectomy. Methods: Ninety-nine consecutive patients undergoing vitrectomy were enrolled. All subjects were preoperatively dilated with tropicamide 1%. Each patient was randomly allocated either in the epinephrine or placebo group. In epinephrine group, patients were submitted to a 0.2 cc subconjunctival injection of a 0.1% epinephrine solution just before first incisions. In placebo group, the same procedure was performed with 0.2 cc of saline 0.9%. Horizontal pupil diameter was measured with calipers before and in the end of the procedure. Results: Patients in the epinephrine group showed a significantly larger mean pupil diameter in the end of the surgery compared to placebo. There was a significant increase of mean pupil diameter from the beginning to the end of the surgery in such patients. Blood pressure was significantly higher in the epinephrine group than in placebo group. No other adverse effects were noted. Conclusion: Subconjunctival epinephrine is effective for maintaining and increasing pupil size during vitrectomy, compared to placebo. Caution should be taken regarding intraoperative blood pressure levels. Trial registration: RBR; RBR-3qzhvg; Registered 8 May 2018—Retrospectively registered, http://www.ensaiosclinicos.gov.br/rg/RBR-3qzhvg/.Keywords
This publication has 30 references indexed in Scilit:
- Comparing the efficacy of mydriatic cocktail-soaked sponge and conventional pupil dilation in patients using tamsulosin – a randomized controlled trialBMC Ophthalmology, 2013
- Use of a New Ocular Insert versus Conventional Mydriasis in Cataract SurgeryBioMed Research International, 2013
- Comparison of phacotrabeculectomy versus phacocanaloplasty in the treatment of patients with concomitant cataract and glaucomaBMC Ophthalmology, 2013
- TOPICAL ADMINISTRATION OF DICLOFENAC (1%) IN THE PREVENTION OF MIOSIS DURING VITRECTOMYRetina, 2008
- Atrial fibrillation following subconjunctival injection of mydricaine number 02Clinical & Experimental Ophthalmology, 2006
- Clinical Case Notes. Tachycardia and myocardial ischaemia following subconjunctival injection of mydricaine (number 02) for vitrectomy procedureClinical & Experimental Ophthalmology, 2005
- The incidence of systemic side-effects following subconjunctival Mydricaine No. 1 injectionEye, 1999
- Persistent tachycardia following subconjunctival injections of mydriatic agents (Mydricaine) used for maintenance of perioperative mydriasis in vitreoretinal surgeryEye, 1995
- Tachycardia and myocardial ischaemia following subconjunctival injection of Mydricaine No. 2Eye, 1994
- MIOSIS DURING VITREORETINAL SURGERYRetina, 1990